Altre lingue TherapeuticsMD, Inc.

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 25/06/2024			Variaz. 5gg	Var. 1 gen.
1,81 ^USD	0,00%		-2,69%	-19,56%

10/05	TherapeuticsMD, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
10/05	TherapeuticsMD, Inc. continua a valutare alternative strategiche	CI

TherapeuticsMD: Q1 Earnings Snapshot	10/05
TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
TherapeuticsMD Announces First Quarter 2024 Financial Results	10/05
TherapeuticsMD, Inc. Continues Evaluation of Strategic Alternatives	10/05
TherapeuticsMD Announces Full Year 2023 Financial Results	01/04
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
TherapeuticsMD Announces Full Year 2023 Financial Results	29/03
Knight Therapeutics Announces Launch of Bijuva in Canada	06/02
Knight Therapeutics Announces Product Launch For IMVEXXY In Canada	04/01
North American Morning Briefing : Stocks Seen Building on CPI Rally; PPI Data Due	15/11
TherapeuticsMD: Q3 Earnings Snapshot	15/11
TherapeuticsMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
TherapeuticsMD Announces Third Quarter 2023 Financial Results	14/11
TherapeuticsMD, Inc. Announces Evaluation of Strategic Alternatives	14/11
ETF: profiteren van de vergrijzing	02/11
TherapeuticsMD, Inc. Announces Executive Changes	18/08/23
TherapeuticsMD: Q2 Earnings Snapshot	14/08/23
TherapeuticsMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
TherapeuticsMD Announces Second Quarter 2023 Financial Results	14/08/23
North American Morning Briefing : Stock Futures -2-	14/08/23

Non ci sono risultati per questa ricerca